Ae Wealth Management LLC Astrazeneca PLC Transaction History

Ae Wealth Management LLC

  • $9.76 Billion
  • Q3 2024

A detailed history of Ae Wealth Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ae Wealth Management LLC holds 8,352 shares of AZN stock, worth $559,667. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,352
Previous 7,660 9.03%
Holding current value
$559,667
Previous $597,000 8.88%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$76.67 - $87.62 $53,055 - $60,633
692 Added 9.03%
8,352 $650,000
Q2 2024

Aug 12, 2024
SELL
$66.81 - $80.83 $7,282 - $8,810
-109 Reduced 1.4%
7,660 $597,000
Q1 2024

May 15, 2024
SELL
$61.03 - $69.57 $1.35 Million - $1.54 Million
-22,100 Reduced 73.99%
7,769 $526,000
Q4 2023

Feb 14, 2024
BUY
$61.89 - $69.28 $722,318 - $808,566
11,671 Added 64.13%
29,869 $2.01 Million
Q3 2023

Oct 11, 2023
SELL
$64.85 - $71.7 $64,590 - $71,413
-996 Reduced 5.19%
18,198 $1.23 Million
Q2 2023

Jul 10, 2023
BUY
$69.91 - $75.81 $169,741 - $184,066
2,428 Added 14.48%
19,194 $1.37 Million
Q1 2023

Apr 14, 2023
SELL
$63.15 - $71.6 $29,869 - $33,866
-473 Reduced 2.74%
16,766 $1.16 Million
Q4 2022

Jan 31, 2023
BUY
$54.21 - $70.44 $14,257 - $18,525
263 Added 1.55%
17,239 $1.17 Million
Q3 2022

Oct 25, 2022
SELL
$53.02 - $135.75 $66,911 - $171,316
-1,262 Reduced 6.92%
16,976 $931,000
Q2 2022

Aug 03, 2022
BUY
$59.26 - $71.14 $129,423 - $155,369
2,184 Added 13.6%
18,238 $1.21 Million
Q1 2022

Apr 18, 2022
SELL
$55.72 - $67.12 $1.53 Million - $1.85 Million
-27,492 Reduced 63.13%
16,054 $1.07 Million
Q4 2021

Jan 20, 2022
BUY
$54.02 - $63.83 $51,859 - $61,276
960 Added 2.25%
43,546 $2.54 Million
Q3 2021

Nov 01, 2021
BUY
$55.56 - $60.79 $90,062 - $98,540
1,621 Added 3.96%
42,586 $2.56 Million
Q2 2021

Jul 21, 2021
SELL
$48.42 - $60.18 $1.16 Million - $1.45 Million
-24,032 Reduced 36.97%
40,965 $2.45 Million
Q1 2021

Apr 27, 2021
BUY
$47.16 - $54.44 $674,435 - $778,546
14,301 Added 28.21%
64,997 $3.23 Million
Q4 2020

Feb 01, 2021
BUY
$48.52 - $58.02 $789,274 - $943,811
16,267 Added 47.25%
50,696 $2.53 Million
Q3 2020

Nov 06, 2020
SELL
$53.07 - $61.1 $57,315 - $65,988
-1,080 Reduced 3.04%
34,429 $1.89 Million
Q2 2020

Aug 05, 2020
BUY
$43.1 - $55.31 $152,487 - $195,686
3,538 Added 11.07%
35,509 $1.88 Million
Q1 2020

May 07, 2020
SELL
$37.79 - $51.33 $863,350 - $1.17 Million
-22,846 Reduced 41.68%
31,971 $1.43 Million
Q4 2019

Jan 15, 2020
BUY
$42.46 - $50.46 $440,777 - $523,825
10,381 Added 23.36%
54,817 $2.73 Million
Q3 2019

Nov 05, 2019
SELL
$40.12 - $45.47 $56,047 - $63,521
-1,397 Reduced 3.05%
44,436 $1.98 Million
Q2 2019

Jul 22, 2019
BUY
$37.28 - $41.68 $933,975 - $1.04 Million
25,053 Added 120.56%
45,833 $1.89 Million
Q1 2019

May 14, 2019
BUY
$35.49 - $43.02 $175,391 - $212,604
4,942 Added 31.2%
20,780 $840,000
Q4 2018

Feb 15, 2019
SELL
$36.86 - $41.49 $469,522 - $528,499
-12,738 Reduced 44.58%
15,838 $602,000
Q3 2018

Nov 14, 2018
BUY
$34.76 - $39.72 $273,005 - $311,960
7,854 Added 37.9%
28,576 $1.13 Million
Q2 2018

Aug 15, 2018
BUY
$34.55 - $37.05 $68,858 - $73,840
1,993 Added 10.64%
20,722 $728,000
Q1 2018

May 14, 2018
SELL
$32.97 - $36.63 $107,482 - $119,413
-3,260 Reduced 14.83%
18,729 $655,000
Q4 2017

Feb 06, 2018
BUY
$32.09 - $34.78 $352 - $382
11 Added 0.05%
21,989 $763,000
Q3 2017

Nov 08, 2017
SELL
$28.96 - $34.0 $19,403 - $22,780
-670 Reduced 2.96%
21,978 $745,000
Q2 2017

Aug 14, 2017
BUY
N/A
22,648
22,648 $772,000

Others Institutions Holding AZN

# of Institutions
1,360
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email